Ireland
--:--IST
Starting soon Not applicable

Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference

NCT06988007 · tracked via the Priya Life Science Belgium tracker
Phase
Not applicable
Started
2027-01-01
Last updated
2026-04-29

Condition(s) studied

Sarcoma

Investigational drug(s) / intervention(s)

Whole body MRI

Whole body MRI: Whole body MRI (ZTE sequence)

Study summary

The goal of this exploratory interventional study aims to evaluate the performance of "pseudo-scanner" MRI sequences in delineating the tumor extent within bone sarcomas and its ability to serve as a reference for designing cutting guides and enabling "navigation" during the surgical procedure, thus exploring the possibility of replacing the scanner to minimize exposure to ionizing radiation in patients with sarcoma.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * diagnosis of bone sarcoma with surgical indication Exclusion Criteria: * Implanted material incompatible with MRI. * Severe claustrophobia. * Pregnant women

Primary outcome measure(s)

  • Evaluation of the absolute error of surgical margins — through study completion, an average of year
    The error values observed in the study by Cartiaux et al. to assess the reduction in absolute error of surgical margins obtained when using a computer-assisted cutting procedure (using 3DSide software installed on a laptop belonging to 3Dside, made available to the doctoral student) compared to freehand cutting are used to size the present study. The objective is to compare the absolute error resulting from a cutting procedure assisted by this 3DSide software based on "pseudo-scanner" imaging with that resulting from the same procedure based on standard scanner imaging.

Trial sites (2)

FacilityCityRegionStatus
Cliniques Universitaires Saint Luc Brussels Belgium
Cliniques universitaires Saint-Luc Brussels Belgium
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06988007 on ClinicalTrials.gov ↗ ← All trials in Belgium